BMS-986504
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for BMS-986504, covering 2025-06-19 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9) [Phase 2]